DSM-Firmenich AG's EBIT per Share for the
six
months ended in Dec. 2025 was CHF-0.22.
Its EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2025 was CHF2.58.
During the past 12 months, the average EBIT per Share Growth Rate of DSM-Firmenich AG was 17.00% per year.
During the past 3 years, the average EBIT per Share Growth Rate was -23.40% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for DSM-Firmenich AG's EBIT per Share or its related term are showing as below:
XSWX:DSFIR'
s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -23.4 Med: -23.4 Max: -23.4
Current: -23.4
During the past 4 years, the highest 3-Year average EBIT per Share Growth Rate of DSM-Firmenich AG was -23.40% per year. The lowest was -23.40% per year. And the median was -23.40% per year.
XSWX:DSFIR's 3-Year EBIT Growth Rate is ranked worse than 78.7% of 1343
companies
in the Chemicals industry
Industry Median: -1.2
vs XSWX:DSFIR: -23.40
DSM-Firmenich AG (XSWX:DSFIR) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
DSM-Firmenich AG EBIT per Share Related Terms
DSM-Firmenich AG EBIT per Share Historical Data
* Premium members only.
The historical data trend for DSM-Firmenich AG's EBIT per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was CHF2.58
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
DSM-Firmenich AG (XSWX:DSFIR) has a EBIT per Share of CHF2.58 as of Dec. 2025. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on DSM-Firmenich AG and its competitors. According to the industry distribution chart, DSM-Firmenich AG ranks #1057 out of 1343 companies in the Chemicals industry, placing it in the top 78.7%.
Is DSM-Firmenich AG's EBIT per Share too high?
DSM-Firmenich AG's current EBIT per Share is CHF2.58. Based on the distribution chart, DSM-Firmenich AG ranks #1057 out of 1343 companies in the Chemicals industry, which is in the bottom quartile relative to peers. Overall, DSM-Firmenich AG has a GF Score™ of 32/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does DSM-Firmenich AG's EBIT per Share compare to LIN and SHW?
According to the Chemicals industry distribution chart, DSM-Firmenich AG ranks #1057 out of 1343 companies for EBIT per Share. This places DSM-Firmenich AG in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for a Chemicals company?
A good EBIT per Share depends on the Chemicals industry context. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on DSM-Firmenich AG and its competitors. DSM-Firmenich AG's current EBIT per Share is CHF2.58. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is DSM-Firmenich AG stock overvalued right now?
Based on GuruFocus' analysis, DSM-Firmenich AG (XSWX:DSFIR) is currently considered Fairly Valued. The stock's GF Value™ is CHF70.90, compared to a current price of CHF74.82 — trading 5.5% above its estimated fair value. The current EBIT per Share is CHF2.58. DSM-Firmenich AG's overall GF Score™ is 32/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For DSM-Firmenich AG (XSWX:DSFIR), the current EBIT per Share is CHF2.58 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is DSM-Firmenich AG (XSWX:DSFIR) Overvalued in 2026?
Based on GuruFocus' analysis, DSM-Firmenich AG stock appears to be overvalued.
The current stock price of CHF74.82 is trading 5.5% above its estimated GF Value™ of CHF70.90.
GuruFocus considers DSM-Firmenich AG to be Fairly Valued.
Key valuation signals for XSWX:DSFIR:
EBIT per Share: CHF2.58
GF Value™: CHF70.90 vs. price of CHF74.82 (5.5% above fair value)
No single metric tells the full story. See the XSWX:DSFIR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
DSM-Firmenich is a global science-based company formed in 2023 through the merger of DSM, a Dutch nutrition, health, and sustainable living player, and Switzerland-based Firmenich, the third-largest player in the flavor and fragrance market. The company serves a wide range of end-consumer markets providing nutrition solutions ranging from medical and early-life nutrition, fragrances for personal-, home-, and laundry-care brands, prestige perfumes, and other ingredients for food and beverage, home, and personal care. DSM-Firmenich has nearly 30,000 employees, with more than 2,000 scientists and engineers spread across 15 research and development facilities.
32GF Score
Get the complete analysis for XSWX:DSFIR
EBIT per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSWX:DSFIR has been successfully added to your 